The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...
Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...
Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...
This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
The UK High Commission, citing its longstanding policy on asylum matters, has declined to comment on Lee Hsien Yang's asylum case. UK newspaper the Guardian recently published an exclusive ...
Current legislation before Congress, including the Modernizing and Ensuring PBM Accountability Act (S.2973) and the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 (S.3430), ...
The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...